Sign in
Taking people in United StatesNo phase

Wearable Device Study for Long COVID Symptom Management

Tests whether wearable devices and education help adults with Long COVID manage symptoms.

Key facts

Who runs it
Scripps Translational Science Institute
Where
La Jolla, United StatesSee the site
Trial code
Registry title
The Long COVID-19 Wearable Device Study
Status
Recruiting
People taking part
100,500 people, planned
Started
16 Nov 2023
Planned end
1 Dec 2025
Type of study
Interventional, 4 groups
Treatments tested
  • Wearable device
Record updated
11 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Long COVID, ME/CFS or POTS who want tools to manage their symptoms and will wear a device and fill in surveys.

Age
18 years or older
Sex
All sexes
Disease stage
Diagnosis of Long COVID (WHO working definition), ME/CFS (self-diagnosis based on IOM criteria) and/or POTS, by yourself and/or a physician

Main reasons for not taking part

  • Cannot join if you do not meet the inclusion criteria
  • Cannot join if you will not wear the device throughout the study and sync data at least weekly
  • Cannot join without a smartphone or tablet to sync the device
  • Cannot join if you will not complete at least 75% of the study surveys

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Is at least 18 years old
  • Has a self/and or physician diagnosis of:
  • Long COVID (based on the WHO working definition),
  • ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or
  • POTS (Postural Orthostatic Tachycardia Syndrome)
  • Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms
  • Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one
  • Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly
  • Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback
  • Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies
  • Agrees to complete at least 75% of the study surveys

Who cannot take part

  • As long as they meet inclusion there is no exclusion

Where in United States

  • Scripps ResearchLa Jolla, United StatesContact: Andrea GoosenTaking people

About the trial

What the trial wants to find out

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

The 4 groups in the trial

  • Control: study provided wearablesOther group

    Following consent and the completion of the baseline assessments the control group will receive basic education on symptom management. At the 3 month timepoint they will be prompted to order their device and receive enhanced education that will provide information on how wearable devices can be used to monitor and manage symptoms.

    Treatment: Wearable device

  • Treatment: study provided wearablesOther group

    Following consent and the completion of the baseline assessments the treatment group will be prompted to order their device and receive basic education on symptom management along with the enhanced education on wearable devices.

    Treatment: Wearable device

  • Control: self provided wearablesOther group

    Following consent and the completion of the baseline assessments the control group will receive basic education on symptom management. At the 3 month timepoint they will be receive enhanced education that will provide information on how wearable devices can be used to monitor and manage symptoms.

    Treatment: Wearable device

  • Treatment: self provided wearablesOther group

    Following consent and the completion of the baseline assessments the treatment group will receive basic education on symptom management along with the enhanced education on wearable devices.

    Treatment: Wearable device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Long COVID-19 Wearable Device Study
Plain-language title
Wearable Device Study for Long COVID Symptom ManagementGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
11 May 2025